{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/novartis-ag-reg/","json":"https://alysly.com/json/markets/stocks/novartis-ag-reg/index.json","lang":"en-US","title":"Novartis AG (NOVN) Stock Price | CH0012005267 | News","description":"Novartis AG (NOVN). Held in 28 ETFs (top 3.23% in SPFS). Health Care stock, Switzerland. ISIN CH0012005267 · WKN 904278.","modified":"2026-11-02T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/novartis-ag-reg/","json":"https://alysly.com/json/de/maerkte/aktien/novartis-ag-reg/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Novartis AG","url":"https://alysly.com/markets/stocks/novartis-ag-reg/"}],"content":[{"type":"heading","level":1,"text":"Novartis AG (NOVN)"},{"type":"paragraph","text":"NOVN · Health Care · Switzerland","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"Switzerland","href":"https://alysly.com/markets/stocks/browse/?country=Switzerland"}]},{"type":"paragraph","text":"Novartis AG (NOVN) is a Swiss company in the Health Care sector. The stock has its largest weight in SPFS (MSCI World Health Care), at 3.23%. Anyone who holds an ETF containing Novartis also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Novartis"},{"type":"heading","level":3,"text":"Key Data for Novartis"},{"type":"facts","items":[{"label":"Held in","value":"28 ETFs"},{"label":"Highest weight","value":"3.23%"},{"label":"Indices","value":"13"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"Switzerland"},{"label":"ISIN","value":"CH0012005267"},{"label":"WKN","value":"904278"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Novartis"},{"type":"heading","level":3,"text":"Novartis Connections"},{"type":"image","alt":"Network diagram: Novartis AG"},{"type":"paragraph","text":"The map shows how Novartis connects to ETFs, indices and other names. Each link is based on measured data and is not a recommendation."},{"type":"list","ordered":false,"items":[{"text":"MSCI Europe Index · contains","links":[{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"}]},{"text":"MSCI World ex USA Index · contains","links":[{"text":"MSCI World ex USA","href":"https://alysly.com/markets/indices/msci-world-ex-usa/"}]},{"text":"MSCI World Health Care Index · contains","links":[{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"}]},{"text":"MSCI World Minimum Volatility Index · contains","links":[{"text":"MSCI World Minimum Volatility","href":"https://alysly.com/markets/indices/msci-world-minimum-volatility/"}]},{"text":"STOXX Europe 600 Index · contains","links":[{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"}]},{"text":"EXSA ETF · holds","links":[{"text":"EXSA","href":"https://alysly.com/markets/etfs/ishares-stoxx-europe-600-ucits-etf-de/"}]},{"text":"X600 ETF · holds","links":[{"text":"X600","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ii-ucits-etf-1c/"}]},{"text":"XESU ETF · holds","links":[{"text":"XESU","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ii-ucits-etf-1d/"}]},{"text":"EXUS ETF · holds","links":[{"text":"EXUS","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ex-usa-ucits-etf-1c/"}]},{"text":"EXU1 ETF · holds","links":[{"text":"EXU1","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ex-usa-ucits-etf-1d/"}]},{"text":"IMEA ETF · holds","links":[{"text":"IMEA","href":"https://alysly.com/markets/etfs/ishares-core-msci-europe-ucits-etf-eur-acc/"}]},{"text":"SPYE ETF · holds","links":[{"text":"SPYE","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-europe-ucits-etf/"}]},{"text":"XDEB ETF · holds","links":[{"text":"XDEB","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-minimum-volatility-ucits-etf-1c/"}]},{"text":"XDWH ETF · holds","links":[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"}]},{"text":"SPFS ETF · holds","links":[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"}]},{"text":"XMEU ETF · holds","links":[{"text":"XMEU","href":"https://alysly.com/markets/etfs/xtrackers-msci-europe-ucits-etf-1c/"}]},{"text":"XSX6 ETF · holds","links":[{"text":"XSX6","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ucits-etf-1c/"}]},{"text":"XIEE ETF · holds","links":[{"text":"XIEE","href":"https://alysly.com/markets/etfs/xtrackers-msci-europe-ucits-etf-1d/"}]},{"text":"XSX7 ETF · holds","links":[{"text":"XSX7","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ucits-etf-1d/"}]},{"text":"Galderma Group N Stock · similar ETF exposure","links":[{"text":"Galderma Group N","href":"https://alysly.com/markets/stocks/galderma-group-ag/"}]},{"text":"Straumann Holding Stock · similar ETF exposure","links":[{"text":"Straumann Holding","href":"https://alysly.com/markets/stocks/straumann-holding-ag-reg/"}]}]},{"type":"paragraph","text":"View the full data network","href":"https://alysly.com/markets/network/"},{"type":"heading","level":3,"text":"What ETF Is Novartis In?"},{"type":"paragraph","text":"Novartis has very high ETF coverage and is held by 28 of the 104 ETFs we track, which together follow 13 indices. That puts the stock in more ETFs than 96.9% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"table","caption":"What ETF is Novartis in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"3.23%","€32.34"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"3.23%","€32.31"],[{"text":"IMEA","href":"https://alysly.com/markets/etfs/ishares-core-msci-europe-ucits-etf-eur-acc/"},{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"},"2.16%","€21.60"],[{"text":"SPYE","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-europe-ucits-etf/"},{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"},"2.13%","€21.32"],[{"text":"XMEU / XIEE","links":[{"text":"XMEU","href":"https://alysly.com/markets/etfs/xtrackers-msci-europe-ucits-etf-1c/"}]},{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"},"2.13%","€21.26"],[{"text":"EXSA","href":"https://alysly.com/markets/etfs/ishares-stoxx-europe-600-ucits-etf-de/"},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"},"2.05%","€20.50"],[{"text":"X600 / XESU","links":[{"text":"X600","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ii-ucits-etf-1c/"}]},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"},"2.02%","€20.15"],[{"text":"XSX6 / XSX7","links":[{"text":"XSX6","href":"https://alysly.com/markets/etfs/xtrackers-stoxx-europe-600-ucits-etf-1c/"}]},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"},"2.01%","€20.08"],[{"text":"2B7K","href":"https://alysly.com/markets/etfs/ishares-msci-world-sri-ucits-etf-eur-acc/"},{"text":"MSCI World SRI","href":"https://alysly.com/markets/indices/msci-world-sri/"},"1.38%","€13.80"],[{"text":"EXUS / EXU1","links":[{"text":"EXUS","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ex-usa-ucits-etf-1c/"}]},{"text":"MSCI World ex USA","href":"https://alysly.com/markets/indices/msci-world-ex-usa/"},"1.19%","€11.93"],[{"text":"XDEB","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-minimum-volatility-ucits-etf-1c/"},{"text":"MSCI World Minimum Volatility","href":"https://alysly.com/markets/indices/msci-world-minimum-volatility/"},"1.19%","€11.87"],[{"text":"XDEM","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-momentum-ucits-etf-1c/"},{"text":"MSCI World Momentum","href":"https://alysly.com/markets/indices/msci-world-momentum/"},"0.96%","€9.63"],[{"text":"WVAL","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-value-ucits-etf-acc/"},{"text":"MSCI World Value","href":"https://alysly.com/markets/indices/msci-world-value/"},"0.83%","€8.27"],[{"text":"XDEQ","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-quality-ucits-etf-1c/"},{"text":"MSCI World Quality","href":"https://alysly.com/markets/indices/msci-world-quality/"},"0.61%","€6.12"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.33%","€3.30"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.33%","€3.30"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.33%","€3.30"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.32%","€3.21"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.29%","€2.90"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.29%","€2.87"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.29%","€2.87"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"0.25%","€2.53"]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Novartis, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Novartis (weight per latest SEC filing): VXUS 0.66%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"VXUS","href":"https://alysly.com/markets/etfs/us/vxus/"}]},{"type":"list","ordered":false,"items":[{"text":"Novartis among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 28 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"Novartis Weight in iShares Core MSCI World (EUNL) Since 2019"},{"type":"image","alt":"Novartis: weight in EUNL 0.45% → 0.33%"},{"type":"paragraph","text":"Sep 30, 2019 Oct 30, 2026"},{"type":"paragraph","text":"In iShares Core MSCI World (EUNL), Novartis had a weight of 0.45% on Sep 30, 2019 and 0.33% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.51% on Mar 31, 2020. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares Core MSCI World (EUNL)","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"}]},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Novartis overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Novartis"},{"type":"table","caption":"Stocks with ETF exposure similar to Novartis","columns":["Stock","Shared ETFs","r"],"rows":[["Novartis","–","–"],[{"text":"Galderma Group N","href":"https://alysly.com/markets/stocks/galderma-group-ag/"},"25","–"],[{"text":"Straumann Holding","href":"https://alysly.com/markets/stocks/straumann-holding-ag-reg/"},"25","–"],[{"text":"Novo Nordisk A/S","href":"https://alysly.com/markets/stocks/novo-nordisk-class-b/"},"25","–"],[{"text":"Glaxosmithkline","href":"https://alysly.com/markets/stocks/glaxosmithkline/"},"25","–"],[{"text":"Alcon","href":"https://alysly.com/markets/stocks/alcon-inc/"},"24","–"],[{"text":"Lonza Group","href":"https://alysly.com/markets/stocks/lonza-group-ag-reg/"},"24","–"],[{"text":"Sonova Holding","href":"https://alysly.com/markets/stocks/sonova-holding-ag-reg/"},"24","–"],[{"text":"Coloplast A/S","href":"https://alysly.com/markets/stocks/coloplast-a-s-class-b/"},"24","–"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Novartis. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: Novartis"},{"type":"heading","level":3,"id":"patents","text":"Latest Patents Granted to Novartis"},{"type":"paragraph","text":"In the 52 weekly issues of the US patent office from Nov 4, 2025 to Oct 27, 2026, Novartis received 69 utility patents. That is 0.022% of all utility patents the US patent office granted in those weeks. The median time from filing to grant was 4.6 years."},{"type":"table","caption":"The five most recent utility patents granted to Novartis","columns":["Granted","Patent","Title","Filed","Technology field"],"rows":[["Oct 27, 2026","US 12774275 B2","Compounds and compositions for the treatment of coronaviral related diseases","Jul 20, 2022","C07D Chemistry; metallurgy"],["Oct 20, 2026","US 12767731 B2","Anti-IgE antibody therapy for multiple food allergies","Sep 17, 2025","C07K Chemistry; metallurgy"],["Oct 20, 2026","US 12767723 B2","Treatment for lupus nephritis using anti-BAFFR antibodies","May 3, 2022","C07K Chemistry; metallurgy"],["Oct 20, 2026","US 12767647 B2","Glue degraders and methods of use thereof","Sep 16, 2020","C07D Chemistry; metallurgy"],["Oct 13, 2026","US 12760031 B2","Pyridine-3-carboxylate compounds as CAV1.2 activators","Dec 12, 2022","C07D Chemistry; metallurgy"]]},{"type":"paragraph","text":"These are grants, not applications. The office usually publishes an application 18 months after the priority date; the grant tends to come much later. Owners counted: NOVARTIS AG. Titles as published by the office; median time based on 39 patents with a known filing date."},{"type":"paragraph","text":"The patent screener lists more grants, filterable by company, type and technology field. The M&A and patents page compares companies.","links":[{"text":"patent screener","href":"https://alysly.com/tools/patent-screener/#c=novartis-ag-reg"},{"text":"M&A and patents","href":"https://alysly.com/m-and-a/"}]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Novartis"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 2, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-3","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-4","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-5","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-6","text":"Grants by the US patent office from its weekly publications (public domain, source: USPTO), counted by the owner at the time of grant."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/novartis-ag-reg/#webpage","url":"https://alysly.com/markets/stocks/novartis-ag-reg/","name":"Novartis AG – Alysly","description":"Novartis AG (NOVN). Held in 28 ETFs (top 3.23% in SPFS). Health Care stock, Switzerland. ISIN CH0012005267 · WKN 904278.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-02T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/novartis-ag-reg/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Novartis AG"}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/novartis-ag-reg/#entity","name":"Novartis AG","tickerSymbol":"NOVN","url":"https://alysly.com/markets/stocks/novartis-ag-reg/","mainEntityOfPage":"https://alysly.com/markets/stocks/novartis-ag-reg/","description":"Novartis AG (NOVN). Held in 28 ETFs (top 3.23% in SPFS). Health Care stock, Switzerland. ISIN CH0012005267 · WKN 904278.","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"NOVN"},{"@type":"PropertyValue","propertyID":"ISIN","value":"CH0012005267"},{"@type":"PropertyValue","propertyID":"WKN","value":"904278"}],"address":{"@type":"PostalAddress","addressCountry":"CH"},"subjectOf":{"@type":"Dataset","name":"Novartis AG — key figures","url":"https://alysly.com/markets/stocks/novartis-ag-reg/","description":"Novartis AG (NOVN). Held in 28 ETFs (top 3.23% in SPFS). Health Care stock, Switzerland. ISIN CH0012005267 · WKN 904278.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":28},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":3.2343},{"@type":"PropertyValue","name":"Sector","value":"Health Care"}]}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}